RecruitingNot ApplicableNCT05323929

The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

200 participants

Start Date

Jan 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a single-center, prospective, group-controlled clinical trial, aiming to clarify the relationship between the depth of dissection and scar formation in the treatment of early gastric cancer by ESD, and to provide high-quality evidence-based medicine for the treatment of early gastric cancer.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether the depth of a wound created during endoscopic submucosal dissection (ESD — a procedure to remove early stomach or colon tumors without open surgery) affects how much scarring forms afterward. **You may be eligible if...** - You have an early-stage gastrointestinal tumor being treated with ESD (endoscopic removal) - You are 18 or older - You consent to biopsy or imaging follow-up after the procedure **You may NOT be eligible if...** - You have contraindications to the ESD procedure - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREESD

Endoscopic Submucosal Dissection for early gastric cancer


Locations(1)

Second affiliated hospital, school of medicine, Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05323929


Related Trials